Skip to main content

and
  1. No Access

    Chapter

    Burkitt’s lymphoma: Multiparametric analysis of 55 cell lines with special reference to morphometry

    The term ‘Burkitt’s lymphoma’ (BL) connotes a specific morphologic appearance which has been well described [1]. However, the boundaries of this entity from other related B-cell lymphomas, especially the small...

    P. Felman, P. A. Bryon, O. Gentilhomme in Malignant Lymphomas and Hodgkin’s Disease:… (1985)

  2. No Access

    Chapter and Conference Paper

    Conclusions

    The evaluation of the management of NHL in Europe shows that many European groups are today in the favourable position of carrying out clinical research competitive with that of the North-American Study Groups...

    S. Monfardini, B. Coiffier, J. Estapé in The Management of Non-Hodgkin’s Lymphomas … (1990)

  3. No Access

    Chapter and Conference Paper

    Stimulation of Peripheral Blood Progenitor Cells by Chemotherapy and Granulocyte-Macrophage Colony-Stimulating Factor in Lymphoproliferative Diseases

    Hematopoietic progenitor cells can be collected from the peripheral blood, cryopreserved, and reinfused after chemotherapy ablation in cancer patients [1]. The advantage of autografting with circulating progen...

    L. Campos, Y. Bastion, N. Roubi, M. Debost in Cytokines in Hemopoiesis, Oncology, and AI… (1992)

  4. No Access

    Chapter

    The management of chronic lymphocytic leukemia — a case history

    Chronic lymphocytic leukemia (CLL) is a common lymphoproliferative disease. In Western countries, CLL is the leukemia with the highest incidence among persons aged 50 to 55 years and older. Hallmarks of the di...

    Y. Bastion, N. Dhedin, P. Felman, B. Coiffier in The Teaching Cases from Annals of Oncology (1997)

  5. No Access

    Chapter and Conference Paper

    Follicular Lymphomas: Morphology, Prognostic Factors and Treatment

    Meaningful discussion of therapy of a disease requires a precise definition of the pathologic entity needing therapy. This requirement is only partially fulfilled for the non-Hodgkin’s lymphomas (NHL). Classif...

    B. Coiffier, F. Berger, F. Giles in Interferons (1997)

  6. No Access

    Chapter and Conference Paper

    Alpha-Interferon Role in the Management of Follicular Lymphoma Patients. The GELA Experience

    Follicular lymphomas (FL) represent between 20 and 25% of all lymphomas and are slightly more frequent in America than in Europe and less frequent in Asia [1]. They are composed of follicle center cells, a mix...

    B. Coiffier in Acute Leukemias VII (1998)

  7. No Access

    Chapter

    Risk-related treatment strategies for diffuse large B cell lymphoma

    Patients with large cell lymphoma have differing prognoses. Even within a single histologic subtype, outcome is influenced by a number of factors (not all of which are recognized), and the optimal treatment di...

    B. Coiffier in Human Lymphoma: Clinical Implications of the REAL Classification (1999)

  8. No Access

    Chapter

    Optimal treatment strategies for peripheral T cell lymphoma (unspecified category)

    This review combines peripheral “T cell lymphoma, unspecified”, whatever the cell morphology and the specific variants described in the REAL classification [29.1]. If one is going to identify clinical differen...

    B. Coiffier in Human Lymphoma: Clinical Implications of the REAL Classification (1999)

  9. No Access

    Chapter

    Clinical aspects and treatment options of B cell CLL/SLL and immunocytoma

    One of the merits of the REAL classification is that it emphasizes different entities and particularly small lymphocytic and lymphoplasmacytic lymphomas. As noted in a preceding chapter, small lymphocytic lymp...

    B. Coiffier in Human Lymphoma: Clinical Implications of the REAL Classification (1999)